Skip to main content

Align Technology Announces Commercial Availability of Previously Announced ClinCheck™ Pro 6.0 and ClinCheck “In-Face” Visualization for Invisalign Treatment

Written by Customer Service on . Posted in Public Companies.

ClinCheck software moves digital treatment planning to the cloud for access anywhere, on any device
Powerful new tool aids digital treatment planning and helps patients visualize personalized treatment outcomes using their photos and 3D modelsSAN JOSE, Calif., Oct. 16, 2020 (GLOBE NEWSWIRE) — Align Technology, Inc. (NASDAQ: ALGN) today announced commercial availability of its previously announced proprietary ClinCheck treatment planning software which will be featured at the Align APAC Virtual Symposium on October 16, a fully digital event to showcase digital treatment techniques and feature practitioners from across the Asia Pacific region. ClinCheck software provides doctors with a 3D model of planned tooth movements throughout Invisalign treatment. ClinCheck Pro 6.0 moves Invisalign digital treatment planning to the cloud, making its robust ClinCheck treatment planning tools and features available to doctors anytime, anywhere, on any laptop, personal computer, or tablet. The release includes the new ClinCheck “In-Face” Visualization tool, an enhanced doctor-facing digital clinical tool that combines a photo of the patient’s face with their 3D Invisalign treatment plan, creating a personalized view of how their new smile could look.ClinCheck “In-Face” Visualization is designed to help doctors with their digital treatment planning and to increase patient understanding of the benefits provided by Invisalign treatment through enhanced visualizations of their personalized treatment outcome. The ClinCheck “In-Face” Visualization workflow combines three components of Align’s digital treatment platform: Invisalign Photo Uploader for patient photos, the iTero intraoral scanner to capture data needed for the 3D model of the patient’s dentition, and ClinCheck Pro 6.0.In addition to ClinCheck “In-Face” Visualization, ClinCheck Pro 6.0 offers users a treatment planning solution that provides doctors with a more intuitive design and an enhanced user experience. This includes improvements to allow doctor modifications through 3D controls and new education features such as dynamic tool tips and product tour. Finally, the cloud-based solution allows doctors to treatment plan with flexibility across devices and ensures that they have the latest version of the software without the need for additional downloads.About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, iTero® intraoral scanners and services, and CAD/CAM software. Align has helped treat over 8 million patients with the Invisalign system and is driving the evolution in digital dentistry with the iTero intraoral scanner and exocad CAD/CAM software − modernizing today’s practices by enabling enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies. Visit www.aligntech.com for more information.Align Technology
Madelyn Homick
(408) 470-1180
mhomick@aligntech.comZeno Group
Sarah Johnson
(828) 551-4201
sarah.johnson@zenogroup.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.